Article info
PDFPostScript
Correspondence
HER2 expression in ovarian carcinoma: caution and complexity in biomarker analysis
- Correspondence to Dr Dana Faratian, Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK; d.faratian{at}ed.ac.uk
Citation
HER2 expression in ovarian carcinoma: caution and complexity in biomarker analysis
Publication history
- First published March 12, 2012.
Online issue publication
July 07, 2020
Article Versions
- Previous version (7 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.